262196 A follow-up assessment of the Pacific Regional Cancer Coalition: Results and implications of a regional coalition to integrate cancer and chronic disease prevention in the Pacific

Tuesday, October 30, 2012 : 8:45 AM - 9:00 AM

Angela Sy, DrPH , School of Nursing and Dental Hygiene, University of Hawaii at Manoa, Honolulu, HI
Ahnate Lim, MA , Department of Psychology, University of Hawaii, Honolulu, HI
Johnny Hedson, MBBS, MMed(Surg) , Department of Health Services, Pohnpei State, Pohnpei State, Micronesia
Lee Buenconsejo-Lum, MD , Department Family Medicine and Community Health, John A. Burns School of Medicine, University of Hawaii, Mililani, HI
Neal Palafox, MD, MPH , Department of Family Medicine and Community Health, John A. Burns School of Medicine, University of Hawaii, Mililani, HI
Significance: The Pacific Regional Cancer Coalition (PRCC) provides regional leadership in the US Affiliated Pacific Islands (USAPI) to implement the Regional Comprehensive Control Plan: and evaluate its coalition and partnerships. The Pacific Center of Excellence in the Elimination of Disparities, aims to reduce cancer disparities and conducts evaluation in the USAPI. In Spring 2010, PRCC Self (internal) and Partner (external) Assessments were conducted to document coalition functioning, regional and national partnerships, sustainability, and the role of regionalism for integrating all chronic disease prevention and control in the Pacific.

Purpose: Follow up PRCC Assessments in Spring 2012 will examine changes in outcomes from the Spring 2010 assessments.

Methods: Self-administered questionnaires and key informant interviews with PRCC members (N=30), and representatives from regional and national partner organizations (N=40) will be conducted. Validated multi item measures using 5 point scales on coalition and partnership characteristics will be used. Inferential statistics will analyze significant changes in partnership measures from the initial assessment.

Results: The initial assessment indicated that internal coalition measures (satisfaction, communication, respect) were rated more highly than external partnership measures (resource sharing, regionalism, use of findings). The follow up assessment will report on changes on these measures.

Conclusions: PRCC member and external partnership satisfaction, and changes in satisfaction will be explained. What has worked to support the PRCC's regional collaborations on cancer prevention programming in the USAPI may be applied to how other regional entities may also work together to integrate all chronic disease prevention and control efforts in the Pacific.

Learning Areas:
Administration, management, leadership
Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Protection of the public in relation to communicable diseases including prevention or control

Learning Objectives:
1) Participants will identify one factor related to satisfaction with the PRCC. 2) Participants will describe partnership factors related to sustainability of cancer prevention and control initiatives in the Pacific from PRCC members and regional and national partners. 3) Participants will identify one strategy on how regionalism may be fostered to address chronic disease prevention in the Pacific region.

Keywords: Asian and Pacific Islander, Collaboration

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am an Assistant Professor with the UH-Office of Public Health Studies. I have served as the evaluator on projects employing community based participatory research approaches to address key health issues in communities experiencing health disparities in Hawaii and the Pacific. I teach Program Evaluation, Community Based Participatory Research, and Needs Assessment to master and DrPH students at UH Office of Public Health Studies.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.